Clinical Trial Update: Beta Glucan's Effect on Pembrolizumab Immunologic Response in Stage III-IV Melanoma [NA]

View source ↗

Summary

Ongoing clinical trial evaluating whether Beta Glucan influences the immunologic response to pembrolizumab in patients with stage III or stage IV melanoma; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Beta Glucan (beta-glucan)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Kelly McMasters | Conditions: Melanoma Stage III, Melanoma Stage IV | NA | Status: RECRUITING